{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:51:13Z","timestamp":1793019073062,"version":"4.5.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,15]]},"DOI":"10.1093\/cid\/ciu623","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T12:21:34Z","timestamp":1414498894000},"page":"S344-S351","source":"Crossref","is-referenced-by-count":214,"title":["Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies"],"prefix":"10.1093","volume":"59","author":[{"given":"Roy F.","family":"Chemaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimpy P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Boeckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"key\n\t\t\t\t20171014001008_CIU623C1","first-page":"203","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients","volume":"2","author":"Shah","year":"2012","journal-title":"Am J Blood Res"},{"key":"key\n\t\t\t\t20171014001008_CIU623C2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/QCO.0b013e3283480440","article-title":"Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients","volume":"24","author":"Renaud","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3324\/haematol.2008.003186","article-title":"Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation","volume":"94","author":"Schiffer","year":"2009","journal-title":"Haematologica"},{"issue":"12 suppl 1","key":"key\n\t\t\t\t20171014001008_CIU623C4","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1053\/bbmt.2001.v7.pm11777098","article-title":"Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience","volume":"7","author":"Nichols","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20171014001008_CIU623C5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2006-12-060343","article-title":"Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection","volume":"110","author":"Peck","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/JCM.25.2.355-357.1987","article-title":"Efficiency of immunofluorescence for rapid detection of common respiratory viruses","volume":"25","author":"Ray","year":"1987","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001008_CIU623C7","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JCM.42.7.2996-2999.2004","article-title":"Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus","volume":"42","author":"Ohm-Smith","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001008_CIU623C8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/INF.0b013e3182481ef8","article-title":"Characteristics and outcomes of pandemic 2009\/H1N1 versus seasonal influenza in children with cancer","volume":"31","author":"Shah","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171014001008_CIU623C9","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2010-11-319186","article-title":"Differences in clinical outcomes following 2009 influenza A\/H1N1 and seasonal influenza among hematopoietic cell transplant recipients","volume":"117","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C10","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/JCM.36.11.3149-3154.1998","article-title":"Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay","volume":"36","author":"Osiowy","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014001008_CIU623C11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/516357","article-title":"Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex)","volume":"26","author":"Fan","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C12","doi-asserted-by":"crossref","first-page":"e26047","DOI":"10.1371\/journal.pone.0026047","article-title":"FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection","volume":"6","author":"Poritz","year":"2011","journal-title":"PLoS One"},{"issue":"9 suppl 4","key":"key\n\t\t\t\t20171014001008_CIU623C13","first-page":"24","article-title":"Rapid multiplex PCR assay to identify respiratory viral pathogens: moving forward diagnosing the common cold","volume":"72","author":"Layman","year":"2013","journal-title":"Hawaii J Med Public Health"},{"key":"key\n\t\t\t\t20171014001008_CIU623C14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2008.07295.x","article-title":"The challenge of respiratory virus infections in hematopoietic cell transplant recipients","volume":"143","author":"Boeckh","year":"2008","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20171014001008_CIU623C15","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/504268","article-title":"Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses","volume":"193","author":"Erard","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-144-5-200603070-00010","article-title":"Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients","volume":"144","author":"Englund","year":"2006","journal-title":"Ann Int Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C17","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1182\/blood-2011-08-371112","article-title":"The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation","volume":"119","author":"Chemaly","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2012.12.019","article-title":"Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement","volume":"19","author":"Seo","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20171014001008_CIU623C19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.11300","article-title":"Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia","volume":"92","author":"Torres","year":"2007","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20171014001008_CIU623C20","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jac\/dkt111","article-title":"Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections","volume":"68","author":"Shah","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/infdis\/jit832","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease","volume":"209","author":"Kim","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/cid\/cit639","article-title":"Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes","volume":"57","author":"Waghmare","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C23","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2010-08-263400","article-title":"Management of RSV infections in adult recipients of hematopoietic stem cell transplantation","volume":"117","author":"Shah","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bmt.2012.134","article-title":"Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients","volume":"48","author":"Molinos-Quintana","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20171014001008_CIU623C25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/tid.12092","article-title":"Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients","volume":"15","author":"Gueller","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/infdis\/jis516","article-title":"An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection","volume":"206","author":"Chemaly","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.201003-0422OC","article-title":"RNA interference therapy in lung transplant patients infected with respiratory syncytial virus","volume":"183","author":"Zamora","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C28","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171014001008_CIU623C29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342412","article-title":"Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation","volume":"186","author":"Cortez","year":"2002","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20171014001008_CIU623C31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2010.03.011","article-title":"Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab","volume":"16","author":"Kassis","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20171014001008_CIU623C32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14712590802610692","article-title":"Palivizumab: where to from here?","volume":"9","author":"Georgescu","year":"2009","journal-title":"Exp Opin Biol Ther"},{"key":"key\n\t\t\t\t20171014001008_CIU623C33","article-title":"Use of high titer RSV immunoglobulin (RI-001-RSV-IVIG) in immunocompromised adults","author":"Falsey"},{"key":"key\n\t\t\t\t20171014001008_CIU623C34","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"An immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with respiratory syncytial virus infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood.V98.3.573","article-title":"Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome","volume":"98","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014001008_CIU623C36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/cid\/ciu134","article-title":"Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplantation: viral detection in the lung predicts outcome","volume":"58","author":"Seo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1203\/00006450-198703000-00013","article-title":"Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat","volume":"21","author":"Gruber","year":"1987","journal-title":"Pediatric Research"},{"key":"key\n\t\t\t\t20171014001008_CIU623C38","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.48.5.1811-1822.2004","article-title":"Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model","volume":"48","author":"Mej\u00edas","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-3062.2012.00718.x","article-title":"Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients","volume":"14","author":"Guzman-Suarez","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/653621","article-title":"A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo","volume":"202","author":"Moscona","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C42","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1093\/cid\/cir501","article-title":"Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation","volume":"53","author":"Chen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/tid.12177","article-title":"DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation","volume":"16","author":"Chalkias","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/AAC.48.5.1495-1502.2004","article-title":"Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo","volume":"48","author":"Alymova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IPC.0b013e3181373cfd","article-title":"Interferon alfa-2b as a successful treatment for parainfluenza virus pneumonia in a non-Hodgkin lymphoma patient","volume":"16","author":"Marinez","year":"2008","journal-title":"Infect Dis Clin Pract"},{"key":"key\n\t\t\t\t20171014001008_CIU623C46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200302273480923","article-title":"Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient","volume":"348","author":"Weinstock","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3201\/eid1704.101429","article-title":"H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients","volume":"17","author":"Renaud","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C48","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/AAC.00476-09","article-title":"Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro","volume":"53","author":"Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C49","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171014001008_CIU623C50","doi-asserted-by":"crossref","first-page":"e7838","DOI":"10.1371\/journal.pone.0007838","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171014001008_CIU623C51","doi-asserted-by":"crossref","first-page":"e7788","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171014001008_CIU623C52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/dkp421","article-title":"DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis","volume":"65","author":"Triana-Baltzer","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jac\/dkq387","article-title":"Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181","volume":"66","author":"Triana-Baltzer","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C54","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.00389-09","article-title":"DAS181 inhibits H5N1 influenza virus infection of human lung tissues","volume":"53","author":"Chan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJMc0910893","article-title":"Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza","volume":"362","author":"Gaur","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C56","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMp0910479","article-title":"The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza","volume":"361","author":"Birnkrant","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/651604","article-title":"Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus","volume":"50","author":"H\u00e4rter","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/infdis\/jit467","article-title":"Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study","volume":"209","author":"Marty","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C60","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C62","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C63","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/656802","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C64","doi-asserted-by":"crossref","first-page":"e1000786","DOI":"10.1371\/journal.ppat.1000786","article-title":"Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171014001008_CIU623C65","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/AAC.01311-09","article-title":"Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration","volume":"54","author":"Kubo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014001008_CIU623C66","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","volume":"57","author":"Fiore","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20171014001008_CIU623C67","article-title":"Oseltamivir prophylaxis significantly reduces the incidence of seasonal influenza infection in immunocompromized patients","author":"Ison","year":"2009"},{"key":"key\n\t\t\t\t20171014001008_CIU623C68","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMc0910060","article-title":"Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis","volume":"361","author":"Baz","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014001008_CIU623C69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014001008_CIU623C70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bmt.2008.264","article-title":"Influenza vaccination in hematopoietic SCT recipients","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/59\/suppl_5\/S344\/20912122\/ciu623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:51:22Z","timestamp":1717491082000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/59\/suppl_5\/S344\/281346\/Management-of-Respiratory-Viral-Infections-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":70,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2014,11,15]]},"published-print":{"date-parts":[[2014,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciu623","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11,15]]},"published":{"date-parts":[[2014,11,15]]}}}